[FEATURES OF CEREBRAL BLOOD FLOW DYNAMICS IN PATIENTS WITH ARTERIAL HYPERTENSION DURING CARDIAC SURGERY]

V Kolesnykov1, O Loskutov1, O Druzhyna1

  • 11Shupyk National Medical Academy of Postgraduated Education, Kyiv; 2Institute of Heart of Ministry of Health of Ukraine, Kyiv, Ukraine.

Georgian Medical News
|March 5, 2019
PubMed

Insights

Mean arterial pressure monitoring is insufficient for evaluating cerebral blood flow during cardiac surgery. Intraoperative monitoring of cerebral blood flow is recommended for patients with arterial hypertension to prevent cognitive dysfunction.

Area of Science:

  • Cardiology
  • Neurology
  • Anesthesiology

Background:

  • Cognitive dysfunction (CD) is a common neurological complication after cardiac surgery, affecting 30%-65% within a month and 20%-40% in the subsequent five months.
  • Arterial hypertension (AH) is a significant risk factor, increasing the relevance of studying cerebral blood flow during procedures like coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To investigate the correlation between mean arterial pressure (MAP) and middle cerebral artery (MCA) blood flow velocity in patients with AH undergoing CABG with cardiopulmonary bypass (CPB).
  • To assess the impact of CPB on cerebral blood flow and identify potential predictors of postoperative cognitive dysfunction.

Main Methods:

  • 128 patients undergoing CABG with CPB were studied, divided into groups with and without AH.
  • Cerebral blood flow was monitored using transcranial Doppler (TCD) and neuropsychological tests (MMSE, FAB, clock drawing, SAGE) were administered.
  • MAP and MCA blood flow velocity were recorded at various surgical stages, including anesthesia induction and hypothermia during CPB.

Main Results:

  • Reduced MCA blood flow velocity was observed during anesthesia induction and CPB-induced hypothermia in both groups.
  • A weak but significant correlation (r=0.099, p=0.004) was found between MAP and MCA blood flow velocity in patients with AH.
  • Patients with AH showed significant declines in MMSE and SAGE test scores postoperatively, unlike the control group.

Conclusions:

  • Mean arterial pressure alone is inadequate for fully assessing cerebral blood flow during CABG with CPB.
  • Intraoperative monitoring of cerebral blood flow is crucial for preventing cognitive dysfunction in patients with AH undergoing cardiac surgery.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.1K
Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
75.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
595
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
8.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
495